MedTrace Logo

Insignia™ Hip Stem Outcomes Study

NCT05144191 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 313

Last updated 2026-05-18

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.

Conditions

  • Hip Osteoarthritis
  • Avascular Necrosis
  • Rheumatoid Arthritis
  • Post-traumatic Osteoarthritis
  • Femoral Neck Fractures
  • Trochanteric Fractures
  • Surgery

Interventions

DEVICE

Insignia uncemented Hip Stem

Device: Replacement of arthritic hip with Insignia uncemented Hip Stem

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-07
Primary Completion
2034-04-02
Completion
2034-04-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144191 on ClinicalTrials.gov